Sunil Narula is an Oncology physician affiliated with University of Chicago. OpenAlex indexes 24 publications with 777 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
22.3%Aromatase Inhibitor8.4%Anastrozole67%Letrozole18%Exemestane15%Part D<11 patientsKinase inhibitor6.2%Jakafi26%Brukinsa22%Cabometyx14%Votrient13%Imatinib Mesylate12%Imbruvica12%Part D<11 patients+ 5 more classes in this area
Metabolism & gastrointestinal
21.3%Corticosteroid7.2%Prednisone100%Part D≥34 patientsSerotonin-3 Receptor Antagonist5.6%Ondansetron Hcl84%Ondansetron Odt16%Part D<11 patients+ 5 more classes in this area
Blood & clotting
19.7%Factor Xa inhibitor14.4%Eliquis76%Xarelto24%Part D≥31 patientsVitamin K antagonist5.3%Warfarin Sodium100%Part D≥17 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Everett Vokes, MD
University of Chicago
Ralph Weichselbaum, MD
University of Chicago
Mary Rinella, MD
University of Chicago
Hedy Kindler, MD
University of Chicago
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”